
Cyclerion Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing the power of soluble guanylate cyclase (sGC) pharmacology to discover, develop and commercialize breakthrough treatments for serious and orphan diseases. Its focus is on enabling the full therapeutic potential of nex... Cyclerion Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing the power of soluble guanylate cyclase (sGC) pharmacology to discover, develop and commercialize breakthrough treatments for serious and orphan diseases. Its focus is on enabling the full therapeutic potential of next-generation sGC stimulators. Its pipeline products include Olinciguat, Praliciguat, and others. Show more
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.0764 | -2.39498432602 | 3.19 | 3.3094 | 2.9 | 12910 | 3.11247307 | CS |
4 | 0.2136 | 7.36551724138 | 2.9 | 3.3094 | 2.7 | 19407 | 3.04326617 | CS |
12 | 0.2636 | 9.24912280702 | 2.85 | 3.79 | 2.4 | 17157 | 3.03036607 | CS |
26 | -0.3564 | -10.2708933718 | 3.47 | 6.25 | 2.28 | 973387 | 4.21666603 | CS |
52 | 0.5436 | 21.1517509728 | 2.57 | 9.4699 | 1.27 | 1256245 | 4.89188317 | CS |
156 | -7.9564 | -71.8735320687 | 11.07 | 25 | 1.27 | 489156 | 5.83414384 | CS |
260 | -86.8864 | -96.5404444444 | 90 | 179.2 | 1.27 | 505029 | 32.52336127 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.